Corvus Pharmaceuticals, Inc. (CRVS) vs InMode Ltd. (INMD)

A side-by-side comparison of Corvus Pharmaceuticals, Inc. and InMode Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Corvus Pharmaceuticals, Inc. logo
CRVS
Corvus Pharmaceuticals, Inc.
$889M
$10.57HealthcareDelayed quote: Oct 6, 2026, 11:49 AM EDT
InMode Ltd. logo
INMD
InMode Ltd.
$804M
$13.99HealthcareDelayed quote: Oct 6, 2026, 11:50 AM EDT

Total return — CRVS vs INMD

growth of $100 · dividends reinvested · last 7y
CRVS +204.2% (+17.2%/yr)INMD +108.1% (+11.0%/yr)CRVS compounded faster over this window
05001k2kStart $100202120232025$304$208
CRVS INMD

CRVS vs INMD: by the numbers

  • •CRVS is the larger company ($889M vs $804M market cap).
  • •INMD is profitable (20.69% net margin) while CRVS runs a net loss (0.00%).

Metrics side by side

Valuation

MetricCRVSINMD
P/E ratioN/A11.37
Forward P/EN/A10.79
PEG ratioN/A1.14
P/S ratioN/A2.15
P/B ratio3.941.28
EV / EBITDAN/A5.90
FCF yieldN/A10.88%

Profitability

MetricCRVSINMD
Gross margin0.00%76.52%
Operating margin0.00%18.47%
Net margin0.00%20.69%
ROE-24.02%12.32%
ROIC-25.25%9.20%

Growth (annualized)

MetricCRVSINMD
Revenue CAGR (5Y)N/A5.42%
EPS CAGR (5Y)N/A6.87%
FCF CAGR (5Y)N/A1.36%
Total return CAGR (5Y)17.88%-27.48%

Frequently asked

Is CRVS or INMD more profitable?
INMD runs the higher net margin — CRVS at 0.00% versus INMD at 20.69%.
How have CRVS and INMD total returns compared?
Over the past 5 years, CRVS delivered 17.88% and INMD delivered -27.48% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CRVS analysisFull INMD analysisInteractive comparison tool

Dig into the metrics

InMode P/E ratioCorvus Pharmaceuticals ROEInMode ROECorvus Pharmaceuticals operating marginInMode operating marginCorvus Pharmaceuticals revenue growthInMode revenue growthCorvus Pharmaceuticals free cash flowInMode free cash flow

Corvus Pharmaceuticals & InMode appear in these rankings

Highest FCF Yield StocksLowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.